One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial

Hung Ling Huang, Meng Rui Lee, Chih Hsin Lee, Meng Hsuan Cheng, Po Liang Lu, Chau Chyun Sheu, Jann Yuan Wang, Inn Wen Chong, Jinn Moon Yang

研究成果: 雜誌貢獻 › 文章 › 同行評審

4 引文 斯高帕斯（Scopus）

指紋

深入研究「One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial」主題。共同形成了獨特的指紋。

Pharmacology, Toxicology and Pharmaceutical Science